References
- Lamberts S W J. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumours. Endocr Rev 1988; 9: 417–436
- Lembcke B, Creutzfeldt W, Schleser S, Ebert R, Shaw C, Koop I. Effects of the somatostatin analogue sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987; 36: 108–124
- van Liessum P A, Hopman W P M, Pieters G F F M, et al. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201–995 in acromegaly. J Clin Endocr Metab 1989; 69: 557–562
- Magnusson I, Einarsson K, Angelin B, Nyberg B, Bergstrom K, Thulin L. Effects of somatostatin on hepatic bile. Gastroenterology 1989; 96: 206–212
- McKnight J A, McCance D R, Crothers J G, Atkinson A B. Changes in glucose tolerance and development of gallstones during high dose treatment with octreotide for acromegaly. Br Med J 1989; 299: 604–605
- Larson L I, Hirsch M A, Hoist J J, et al. Pancreatic somatostatinoma: clinical features and physiological implications. Lancet 1977; 1: 666–668
- Masclee A A M, Hopman W P M, Corstens F H M, Rosenbuch G, Jansen J B M J, Lamers C B H W. Simultaneous measurements of gallbladder emptying with cholescintigraphy and ultrasound during infusion of physiologic doses of cholecystokinin: a comparison. Radiology 1989; 173: 407–410